why choose us

First received: February 07, 2023

Clinical Trial: A Study of TL-925 as a Treatment for Dry Eye Disease

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Dry Eye Disease

Study Type: INTERVENTIONAL


Official Title: A Phase 2, Multicenter, Randomized, Double-masked, Placebo-controlled Study to Evaluate the Safety and Tolerability of TL-925 Ophthalmic Emulsion 0.1% in Subjects With Moderate to Severe Dry Eye Disea

Brief Summary: In this prospective, Phase 2, multicenter, randomized, double-masked, placebo-controlled, parallel-arm study, approximately 100 subjects with moderate to severe dry eye disease (DED) will be randomly assigned (1:1) to receive either TL-925 or placebo as topical ophthalmic eye drops administered bilaterally BID.The study will comprise two phases: 2-weeks screening/run-in and 4-weeks double-masked treatment.

Read more